EUVIMEDEUVIMED entdecken
Studienprotokoll

QIM26-310: Reducing Hospital Readmissions for Oncology Patients Receiving Chemotherapy Through a Pharmacist-Led Febrile Neutropenia Risk-Assessment Protocol (Pilot)

Merja Aziz, Paula Haines, Colleen Bramwell, Ummul Zakia, Parampreet Kaur, Melissa Wilson

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7244 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Merja Aziz und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1St. Luke's University, Bethlehem, PA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1St. Luke's University, Bethlehem, PA.

Zitieren

APA

Aziz, M., Haines, P., Bramwell, C., Zakia, U., Kaur, P., & Wilson, M. (2026). QIM26-310: Reducing Hospital Readmissions for Oncology Patients Receiving Chemotherapy Through a Pharmacist-Led Febrile Neutropenia Risk-Assessment Protocol (Pilot). Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7244

Vancouver

Aziz M, Haines P, Bramwell C, Zakia U, Kaur P, Wilson M. QIM26-310: Reducing Hospital Readmissions for Oncology Patients Receiving Chemotherapy Through a Pharmacist-Led Febrile Neutropenia Risk-Assessment Protocol (Pilot). Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7244

BibTeX
@article{Aziz2026,
  author = {Aziz, Merja and Haines, Paula and Bramwell, Colleen and Zakia, Ummul and Kaur, Parampreet and Wilson, Melissa},
  title = {QIM26-310: Reducing Hospital Readmissions for Oncology Patients Receiving Chemotherapy Through a Pharmacist-Led Febrile Neutropenia Risk-Assessment Protocol (Pilot)},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7244}
}
Kostenlos starten →